All News
RheumNow Podcast - RWCS Quick Hits (2.14.20)
Dr. Jack Cush reviews the highlights from the 2020 RWCS meeting in Maui, Hawaii.
Read Article
Cool way to visualize Rx options in PsA. Data from A Kavanaugh #RWCS2020 @RheumNow https://t.co/XobnUbVhiA
Janet Pope Janetbirdope ( View Tweet)
Guidelines from GRAPPA are more inclusive than ACR. ACR lacks most MOA drugs other than TNFis #RWCS2020 @RheumNow https://t.co/7k4HCllzfE
Janet Pope Janetbirdope ( View Tweet)
EXCEED SECU vs ADA results in treatment naive pts. #RWCS2020 @RheumNow @RWCSmtg https://t.co/VF7Y7p4H2H
Dr. Rachel Tate uptoTate ( View Tweet)
REMS is nothing to sleep about Not REM sleep but FDA may impose risk mitigation strategies post marketing. It applies to some drugs such as Coxibs and Actemra vs Etanercept ENTRACT RCT for CV safety and Belimumab in SLE for safety. All equally safe #RWCS2020 @RheumNow https://t.co/b3rDlcABwL
Janet Pope Janetbirdope ( View Tweet)
A review of the 2015 GRAPPA guidelines from Drs. Kavanaugh and Ruderman #RWCS2020 @RheumNow @RWCSmtg https://t.co/45P3VzR4hj
Dr. Rachel Tate uptoTate ( View Tweet)
SEAM results make the case that ETN + MTX may have improved skin scores compared to ETN or MTX monotherapy. @RheumNow @RWCSmtg #RWCS2020 https://t.co/CErP4HOejA
Dr. Rachel Tate uptoTate ( View Tweet)
PsA domains, as a way to discuss the heterogeneity of disease. Drs. Kavanaugh and Ruderman #RWCS2020 @RheumNow @RWCSmtg https://t.co/NKwE4xj63l
Dr. Rachel Tate uptoTate ( View Tweet)
Axial SpA if on adalimumab should MTX be used to decrease ABs? Study says YE and pretreat so MTX first. Not standard of care. #RWCS2020 @RheumNow https://t.co/d7YOwqoUwN
Janet Pope Janetbirdope ( View Tweet)
Secukinumab is not stat superior to Adalimumab for primary endpoint in PsA. Equal but some features are better. Do 2 IL17 H2H trials make you change order of biological Rx? #RWCS2020 @RheumNow https://t.co/ZRc1Y4MTQ4
Janet Pope Janetbirdope ( View Tweet)
Joint surgeries are more common in PsA compared to the general population, even in the biologics era. Drs. Ruderman/Kavanaug #RWCS2020 @RWCSmtg https://t.co/R0BPUQvLV7
Dr. John Cush RheumNow ( View Tweet)
Having PsA involves 2-3-4 domains in 74% of pts.. Drs. Ruderman/Kavanaug #RWCS2020 @RWCSmtg https://t.co/hJUxqQYZf3
Dr. John Cush RheumNow ( View Tweet)
New GRAPPA treatment guidelines for psoriatic arthritis. Drs. Ruderman/Kavanaug #RWCS2020 @RWCSmtg https://t.co/uOsSabCzjB
Dr. John Cush RheumNow ( View Tweet)
"History will be kind to me for I intend to write it." - Winston Churchill
Dr. John Cush RheumNow ( View Tweet)
See proses criteria https://t.co/l046MENA8A https://t.co/aEVBU3idYn
Janet Pope Janetbirdope ( View Tweet)
Hip replacement is more satisfying than TKR. In general OA does better than RA #RWCS2020 @RheumNow https://t.co/qHozUmW8oe
Janet Pope Janetbirdope ( View Tweet)
The type of THR predicts durability & for TKR pre op flexion predicts post op flexion not the replacement. Work on ROM for knee pre op. Dr Wm Bugbee #RWCS2020 @RheumNow https://t.co/xMf3jEUewK
Janet Pope Janetbirdope ( View Tweet)
JIA uveitis. Think of +ANA pauciarticular pts at high risk. Often chronic uveitis asymptotic so reg eye tests needed. + data with less Rx failure with adalimumab vs placebo Alvin Wells @RheumNow #RWCS2020 https://t.co/NAehhiD2gM
Janet Pope Janetbirdope ( View Tweet)
Out of control- injection of stuff into knee. Amniotic fluid, stem cells etc. NEED proper data. Not regulated and unproven. Wm Bugbee #RWCS2020 @RheumNow https://t.co/WNOMaXEZSm
Janet Pope Janetbirdope ( View Tweet)
Different classification of allergic Rxns. Dr Anna Postolova #RWCS2020 @RheumNow https://t.co/3nVQer3vUt
Janet Pope Janetbirdope ( View Tweet)
